Butterfly Network, Inc.
BFLYMedical Devices
$6.39−14.91%As of Oct 30vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- –
- From 52W high
- −35.65%
- EPS (LTM)
- -$0.21
- Revenue (LTM)
- $123.3M
- Net margin
- -43.56%
Nomior Score
54
Steady ProfileSpeculativeTop 40% of the scored universe
Growth66
Quality36
Value40
Momentum96
Resilience29
Growth
+23.45%revenue a year over 6 fiscal years
YE19 $27.6MLTM $123.3M
Connections
Revenue to profitQ3 FY26
The operating loss was 42% of revenue, narrower by 122 pts on a year.
Latest resultsthird quarter 2026
- Revenue
- $32.6 million
- Net loss
- $12.8 million
- Adjusted loss per share
- $(0.01)
Revenue rose in the quarter, driven by U.S. sales tied to Embedded partnerships and higher probe sales, while international sales declined. The net loss and adjusted EBITDA loss narrowed from the prior year, and gross margin reached a company high. Management raised its full-year revenue and adjusted EBITDA guidance.
Who owns it
2funds, 1 tracked portfolio